Cargando…
液体活检及其在非小细胞肺癌诊治中的研究进展
With the advances of technology, great progresses have been made in liquid biopsy in recent years. Liquid biopsy is currently playing a more and more important role in early diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy is more popular in clinical practice...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015208/ https://www.ncbi.nlm.nih.gov/pubmed/27335304 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.06.19 |
_version_ | 1783334362969800704 |
---|---|
collection | PubMed |
description | With the advances of technology, great progresses have been made in liquid biopsy in recent years. Liquid biopsy is currently playing a more and more important role in early diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy is more popular in clinical practice due to its non-invasiveness, convenience and high repeatability. It has huge potential in the future. This review introduces circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as the most important objects in liquid biopsy, mainly focusing on their history, biological characteristics, detection technologies, limitations and applications in non-small cell lung cancer. |
format | Online Article Text |
id | pubmed-6015208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60152082018-07-06 液体活检及其在非小细胞肺癌诊治中的研究进展 Zhongguo Fei Ai Za Zhi 2016胸外医师年会特约专题:早期肺癌 With the advances of technology, great progresses have been made in liquid biopsy in recent years. Liquid biopsy is currently playing a more and more important role in early diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy is more popular in clinical practice due to its non-invasiveness, convenience and high repeatability. It has huge potential in the future. This review introduces circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as the most important objects in liquid biopsy, mainly focusing on their history, biological characteristics, detection technologies, limitations and applications in non-small cell lung cancer. 中国肺癌杂志编辑部 2016-06-20 /pmc/articles/PMC6015208/ /pubmed/27335304 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.06.19 Text en 版权所有©《中国肺癌杂志》编辑部2016 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 2016胸外医师年会特约专题:早期肺癌 液体活检及其在非小细胞肺癌诊治中的研究进展 |
title | 液体活检及其在非小细胞肺癌诊治中的研究进展 |
title_full | 液体活检及其在非小细胞肺癌诊治中的研究进展 |
title_fullStr | 液体活检及其在非小细胞肺癌诊治中的研究进展 |
title_full_unstemmed | 液体活检及其在非小细胞肺癌诊治中的研究进展 |
title_short | 液体活检及其在非小细胞肺癌诊治中的研究进展 |
title_sort | 液体活检及其在非小细胞肺癌诊治中的研究进展 |
topic | 2016胸外医师年会特约专题:早期肺癌 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015208/ https://www.ncbi.nlm.nih.gov/pubmed/27335304 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.06.19 |
work_keys_str_mv | AT yètǐhuójiǎnjíqízàifēixiǎoxìbāofèiáizhěnzhìzhōngdeyánjiūjìnzhǎn AT yètǐhuójiǎnjíqízàifēixiǎoxìbāofèiáizhěnzhìzhōngdeyánjiūjìnzhǎn |